Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis.

CompletedOBSERVATIONAL
Enrollment

259

Participants

Timeline

Start Date

January 2, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

October 31, 2019

Conditions
Psoriatic ArthritisInflammatory Bowel Diseases
Interventions
DIAGNOSTIC_TEST

Fecal calprotectin assay

FC levels were measured at baseline with Bühlmann fCAL Turbo, Switzerland® kit.

Trial Locations (1)

59100

Fabrizio Cantini, Prato

All Listed Sponsors
collaborator

Giulia Franchi,Department of Rheumatology, Hospital of Prato

UNKNOWN

collaborator

Maurizio Benucci,S.Giovanni di Dio Hospital

UNKNOWN

collaborator

Raffaele Scarpa, Rheumatology Unit, University of Naples Federico II, Naples

UNKNOWN

collaborator

Francesco Caso, Rheumatology Unit, University of Naples Federico II, Naples

UNKNOWN

collaborator

Rosario Foti,Rheumatology Unit, A.O.U. Policlinico Vittorio Emanuele, Catania

UNKNOWN

collaborator

Antonio Carletto,Rheumatology Unit, AOUI, Verona.

UNKNOWN

collaborator

Elisa Visalli,Rheumatology Unit, A.O.U. Policlinico Vittorio Emanuele, Catania

UNKNOWN

collaborator

Laura Niccoli,Department of Rheumatology, Hospital of Prato

UNKNOWN

lead

Hospital of Prato

OTHER

NCT04190108 - Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis. | Biotech Hunter | Biotech Hunter